UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increase in stress contributes to impaired jaw function in juvenile idiopathic arthritis: a two-year prospective study

Pediatric rheumatology online journal, 2024-02, Vol.22 (1), p.30-30, Article 30

2024

Volltextzugriff (PDF)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Arthritis research & therapy, 2019-11, Vol.21 (1), p.259-259, Article 259

2019

Volltextzugriff (PDF)

SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic

Frontiers in immunology, 2021-08, Vol.12, p.724047-724047

2021

Volltextzugriff (PDF)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

International journal of molecular sciences, 2020-05, Vol.21 (10), p.3463

2020

Volltextzugriff (PDF)

Smoking reduces the efficacy of belimumab in mucocutaneous lupus

Expert opinion on biological therapy, 2018-08, Vol.18 (8), p.911-920

2018

Volltextzugriff (PDF)

Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish Patients

Frontiers in medicine, 2021-02, Vol.8, p.646846-646846

2021

Volltextzugriff (PDF)

NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic

Cells (Basel, Switzerland), 2022-08, Vol.11 (17), p.2619

2022

Volltextzugriff (PDF)

O6 Epidemiology of moderate-to-severe SLE in Sweden

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A10-A11

2024

Volltextzugriff (PDF)

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

Microbiology spectrum, 2024, Vol.12 (4), p.e0298123-e0298123

2024

Volltextzugriff (PDF)

Screening for autoimmune diseases in apparently healthy antinuclear antibody positive individuals

Frontiers in medicine, 2024, Vol.11, p.1455673

2024

Volltextzugriff (PDF)

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register

BMJ open, 2013-01, Vol.3 (10), p.e003608-e003608

2013

Volltextzugriff (PDF)

O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A9-A10

2024

Volltextzugriff (PDF)

P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A98-A98

2024

Volltextzugriff (PDF)

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus

Lupus science & medicine, 2023, Vol.10 (2), p.e000926

2023

Volltextzugriff (PDF)

Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality-a national cohort study

Rheumatology (Oxford, England), 2024-04, Vol.63 (4), p.1104-1112

2024

Volltextzugriff (PDF)

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts

Lupus, 2019-09, Vol.28 (10), p.1261-1272

2019

Volltextzugriff (PDF)

Longitudinal anti‐nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent‐onset disease

Clinical and experimental immunology, 2020-03, Vol.199 (3), p.245-254

2020

Volltextzugriff (PDF)

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

Annals of the rheumatic diseases, 2020-03, Vol.79 (3), p.363-369

2020

Volltextzugriff (PDF)

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

Autoimmunity reviews, 2017-04, Vol.16 (4), p.343-351

2017

Volltextzugriff (PDF)

The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)

Vaccine, 2023, Vol.41 (20), p.3247-3257

2023

Volltextzugriff (PDF)

Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus

Lupus, 2020-05, Vol.29 (6), p.625-630

2020

Volltextzugriff (PDF)

NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.254-261

2020

Volltextzugriff (PDF)

Parotid saliva and blood biomarkers in juvenile idiopathic arthritis in relation to temporomandibular joint magnetic resonance imaging findings

Journal of oral rehabilitation, 2024-10, Vol.51 (10), p.2082-2092

2024

Volltextzugriff (PDF)

Antinuclear and Antiphospholipid Antibodies Versus Disease Manifestations and Clinical Outcomes in Systemic Lupus Erythematosus

Frodlund, Martina

2020

Volltextzugriff (PDF)

Immunoglobulin A anti‐phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual

Clinical and experimental immunology, 2018-10, Vol.194 (1), p.27-38

2018

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)
Dissertationen
(1)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Increase in stress contributes to impaired jaw function in juvenile idiopathic arthritis: a two-year prospective study

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

Smoking reduces the efficacy of belimumab in mucocutaneous lupus

Longitudinal Analysis of Anti-cardiolipin and Anti-β2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus: A Prospective Study in Swedish Patients

NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic

O6 Epidemiology of moderate-to-severe SLE in Sweden

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

Screening for autoimmune diseases in apparently healthy antinuclear antibody positive individuals

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register

O4 Clinical characteristics of patients with high SLE-specific and high multitrait polygenic risk – An investigation of SLE risk loci

P77 Identification of a cluster of SLE risk loci associated with levels of multiple blood biomarkers in the general population – Implication for SLE sub-phenotypes

B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus

Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality-a national cohort study

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts

Longitudinal anti‐nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent‐onset disease

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)

Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus

NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus

Parotid saliva and blood biomarkers in juvenile idiopathic arthritis in relation to temporomandibular joint magnetic resonance imaging findings

Antinuclear and Antiphospholipid Antibodies Versus Disease Manifestations and Clinical Outcomes in Systemic Lupus Erythematosus

Immunoglobulin A anti‐phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual

Suchergebnisse filtern